Edwards Lifesciences Corp (EW)
Health Care – ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
- Headquarters
- United States
- Employees
- 16,000
- Market Cap
- $48.2B
About Edwards Lifesciences Corp
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
SentiSense also tracks daily options readings for Edwards Lifesciences Corp: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Edwards Lifesciences Corp stock analysis, sentiment tracking, and market intelligence on SentiSense.